CytomX Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $37.3M | $-116.0M | $-115.9M |
| FY2022 | $53.2M | $-101.3M | $-99.3M |
| FY2023 | $101.2M | $-6.5M | $-569.0K |
| FY2024 | $138.1M | $25.0M | $31.9M |
| FY2025 | $76.2M | $-22.4M | $-17.4M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $37.3M | $-116.0M | $-115.9M |
| FY2022 | $53.2M | $-101.3M | $-99.3M |
| FY2023 | $101.2M | $-6.5M | $-569.0K |
| FY2024 | $138.1M | $25.0M | $31.9M |
| FY2025 | $76.2M | $-22.4M | $-17.4M |